国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2009年
8期
632-634
,共3页
樊卫飞%王峻%杨民%刘福银%孟丽娟
樊衛飛%王峻%楊民%劉福銀%孟麗娟
번위비%왕준%양민%류복은%맹려연
奥沙利铂%白细胞介素2%高温%诱发%药物疗法%腹水
奧沙利鉑%白細胞介素2%高溫%誘髮%藥物療法%腹水
오사리박%백세포개소2%고온%유발%약물요법%복수
Oxaliplatin%Interleukin-2%Hyperthermia%induced%Drug therapy%Ascites
目的研究奥沙利铂(L-OHP)加白介素-2(IL-2)腹腔热化疗联合静脉化疗治疗老年癌性腹腔积液的疗效和不良反应.方法将42例消化系统肿瘤来源的癌性腹腔积液患者引出腹腔积液后,在加热的5%葡萄糖溶液2 000~2 500 mi中加入L-OHP 85 ms/m2及IL-2(2 MU),用NRL-002型内生场肿瘤热疗系统行腹部局部热疗,腹腔内温度保持在41~43℃,持续60~120 min.腹腔热化疗后第2天,给予静脉化疗,予以亚叶酸钙(CF)0.2 s/m2静滴2 h,氟尿嘧啶(5-FU)0.4 s/m2静推,1.6 g/m2持续静脉输注46 h,每2周重复.结果42例患者近期治疗总有效率为66.67%,其中完全缓解(CR)6例,部分缓解(PR)22例,稳定(NC)6例,无效(PD)8例,中位生存时间(MST)为5.6个月,主要毒性表现为急性腹痛、麻痹性肠梗阻.结论L-OHP加IL-2腹腔热化疗联合静脉化疗治疗老年癌性腹腔积液具有一定的疗效,不良反应轻,且能提高患者生存质量,值得进一步研究.
目的研究奧沙利鉑(L-OHP)加白介素-2(IL-2)腹腔熱化療聯閤靜脈化療治療老年癌性腹腔積液的療效和不良反應.方法將42例消化繫統腫瘤來源的癌性腹腔積液患者引齣腹腔積液後,在加熱的5%葡萄糖溶液2 000~2 500 mi中加入L-OHP 85 ms/m2及IL-2(2 MU),用NRL-002型內生場腫瘤熱療繫統行腹部跼部熱療,腹腔內溫度保持在41~43℃,持續60~120 min.腹腔熱化療後第2天,給予靜脈化療,予以亞葉痠鈣(CF)0.2 s/m2靜滴2 h,氟尿嘧啶(5-FU)0.4 s/m2靜推,1.6 g/m2持續靜脈輸註46 h,每2週重複.結果42例患者近期治療總有效率為66.67%,其中完全緩解(CR)6例,部分緩解(PR)22例,穩定(NC)6例,無效(PD)8例,中位生存時間(MST)為5.6箇月,主要毒性錶現為急性腹痛、痳痺性腸梗阻.結論L-OHP加IL-2腹腔熱化療聯閤靜脈化療治療老年癌性腹腔積液具有一定的療效,不良反應輕,且能提高患者生存質量,值得進一步研究.
목적연구오사리박(L-OHP)가백개소-2(IL-2)복강열화료연합정맥화료치료노년암성복강적액적료효화불량반응.방법장42례소화계통종류래원적암성복강적액환자인출복강적액후,재가열적5%포도당용액2 000~2 500 mi중가입L-OHP 85 ms/m2급IL-2(2 MU),용NRL-002형내생장종류열료계통행복부국부열료,복강내온도보지재41~43℃,지속60~120 min.복강열화료후제2천,급여정맥화료,여이아협산개(CF)0.2 s/m2정적2 h,불뇨밀정(5-FU)0.4 s/m2정추,1.6 g/m2지속정맥수주46 h,매2주중복.결과42례환자근기치료총유효솔위66.67%,기중완전완해(CR)6례,부분완해(PR)22례,은정(NC)6례,무효(PD)8례,중위생존시간(MST)위5.6개월,주요독성표현위급성복통、마비성장경조.결론L-OHP가IL-2복강열화료연합정맥화료치료노년암성복강적액구유일정적료효,불량반응경,차능제고환자생존질량,치득진일보연구.
Objective To evaluate the effects and toxicities of the hyperthermic peritoneal peffusion with oxaliplatin (L-OHP) and interleukin-2 (IL-2) combined with chemotherapy for treatment malignant asci-tes. Methods 42 patients with malignant aacites from assimilation system tumor were catheterized,drained and flushed with L-OHP 85 mg/m2 in 2 000 ~2 500 ml of 5 % glucose and IL-2(2 MU),NRL-001 Double RF tumor hyperthermia system was applied to heat the abdominal part for 60 ~ 120 minutes at an intraperitoneal temperature of 41 -43 ℃ ,next day,all the patients were treated with calcium folinate(CF)0. 2 g/m2 by 2 hours intravenous infusion,5-fluorouracil (5-FU) 0. 4 g/m2 intravenously, followed by 46 hours continuous infusion of 5-FU (1 600 mg/m2), 2 weeks a cycle. Results The overall response rate was 66. 67%, including CR : 6 cases, PR:22 cases, NC:6 cases, and PD:8 cases. MST is 5.6 months. The main toxicity was impatient abdomen ache,paralysis intestinal obstruction. Conclusion Hyperthermic peritoneal perfusion with oxaliplatin and inter-leukin-2 combined with chemotherapy is efficient and safe in the treatment malignant ascites and can improve the quality of life. It is worthing wildly using and research.